A detailed history of Strategic Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Strategic Advisors LLC holds 4,461 shares of VRTX stock, worth $1.8 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
4,461
Previous 4,461 -0.0%
Holding current value
$1.8 Million
Previous $2.09 Million 0.77%
% of portfolio
0.39%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$392.81 - $485.53 $1.53 Million - $1.9 Million
3,905 Added 702.34%
4,461 $2.09 Million
Q1 2024

Apr 19, 2024

BUY
$407.69 - $446.08 $12,638 - $13,828
31 Added 5.9%
556 $232,000
Q4 2023

Jan 19, 2024

BUY
$343.0 - $410.68 $180,075 - $215,607
525 New
525 $213,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $103B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Strategic Advisors LLC Portfolio

Follow Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.